Identification of FN1BP1 as a Novel Cell Cycle Regulator through Modulating G1 Checkpoint in Human Hepatocarcinoma Hep3B Cells

Liu, Mei; Wu, Ronghua; Yang, Fuye; Wang, Tao; Zhang, Pingping; Gu, Jianren; Wan, Dafang; Yang, Shengli
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
A novel human gene, FN1BP1 (fibronectin 1 binding protein 1), was identified using the human placenta cDNA library. Northern blotting showed a transcript of ∼2.8 kb in human placenta, liver, and skeletal muscle tissues. This mRNA transcript length was similar to the full FN1BP1 sequence obtained previously. We established a conditionally induced stable cell line of Hep3B-Tet-on-FN1BP1 to investigate the preliminary function and mechanism of the secretory FN1BP1 protein. Cell-proliferation and colony-conformation assays demonstrated that FN1BP1 protein suppressed Hep3B cell growth and colonization in vitro. Analysis of Atlas human cDNA expression indicated that after FN1BP1 Dox-inducing expression for 24 h, 19 genes were up-regulated and 22 genes were down-regulated more than two-fold. Most of these gene changes were related to cell-cycle-arrest proteins (p21cip1, p15, and cyclin E1), transcription factors (general transcription factors, zinc finger proteins, transcriptional enhancer factors), SWI/SNF (SWItch/Sucrose NonFermentable) complex units, early-response proteins, and nerve growth or neurotrophic factors. Down-regulated genes were subject to colony-stimulating factors (e.g., GMSFs), and many repair genes were involved in DNA damage (RAD, ERCC, DNA topoisomerase, polymerase, and ligase). Some interesting genes (p21cip1, ID2, GMSF, ERCC5, and RPA1), which changed in the cDNA microarray analysis, were confirmed by semi-qRT-PCR, and similar changes in expression were observed. FCM cell-cycle analysis indicated that FN1BP1 over-expression could result in G1 phase arrest. FN1BP1 might inhibit cell growth and/or colony conformation through G1 phase arrest of the Hep3B cell cycle. These results indicate the potential role of FN1BP1 as a treatment target for hepatocellular carcinoma.


Related Articles

  • Lack of the Matricellular Protein SPARC (Secreted Protein, Acidic and Rich in Cysteine) Attenuates Liver Fibrogenesis in Mice. Atorrasagasti, Catalina; Peixoto, Estanislao; Aquino, Jorge B.; Kippes, Néstor; Malvicini, Mariana; Alaniz, Laura; Garcia, Mariana; Piccioni, Flavia; Fiore, Esteban J.; Bayo, Juan; Bataller, Ramón; Guruceaga, Elizabeth; Corrales, Fernando; Podhajcer, Osvaldo; Mazzolini, Guillermo // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Introduction: Secreted Protein, Acidic and Rich in Cysteine (SPARC) is a matricellular protein involved in many biological processes and found over-expressed in cirrhotic livers. By mean of a genetic approach we herein provide evidence from different in vivo liver disease models suggesting a...

  • In Silico Estimation of Translation Efficiency in Human Cell Lines: Potential Evidence for Widespread Translational Control. Stevens, Stewart G.; Brown, Chris M // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Recently large scale transcriptome and proteome datasets for human cells have become available. A striking finding from these studies is that the level of an mRNA typically predicts no more than 40% of the abundance of protein. This correlation represents the overall figure for all genes. We...

  • Voting-Based Cancer Module Identification by Combining Topological and Data-Driven Properties. Azad, A. K. M.; Lee, Hyunju // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Recently, computational approaches integrating copy number aberrations (CNAs) and gene expression (GE) have been extensively studied to identify cancer-related genes and pathways. In this work, we integrate these two data sets with protein-protein interaction (PPI) information to find...

  • Clustering Gene Expression Regulators: New Approach to Disease Subtyping. Pyatnitskiy, Mikhail; Mazo, Ilya; Shkrob, Maria; Schwartz, Elena; Kotelnikova, Ekaterina // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    One of the main challenges in modern medicine is to stratify different patient groups in terms of underlying disease molecular mechanisms as to develop more personalized approach to therapy. Here we propose novel method for disease subtyping based on analysis of activated expression regulators...

  • Prognostic Significance of EBV Latent Membrane Protein 1 Expression in Lymphomas: Evidence from 15 Studies. Mao, Yuan; Lu, Mei Ping; Lin, Hong; Zhang, Da Wei; Liu, Ying; Li, Qing Dong; Lv, Zhi Gang; Xu, Jia Ren; Chen, Ren Jie; Zhu, Jin // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    Background: Epstein-Barr virus (EBV) infection has been associated with lymphoma development. EBV latent membrane protein 1 (LMP1) is essential for EBV-mediated transformation and progression of different human cells, including lymphocytes. This meta-analysis investigated LMP1 expression with...

  • Dynamic Gene Expression Changes Precede Dioxin-Induced Liver Pathogenesis in Medaka Fish. Volz, David C.; Hinton, David E.; Law, J. McHugh; Kullman, Seth W. // Toxicological Sciences;Feb2006, Vol. 89 Issue 2, p524 

    A major challenge for environmental genomics is linking gene expression to cellular toxicity and morphological alteration. Herein, we address complexities related to hepatic gene expression responses after a single injection of the aryl hydrocarbon receptor (AHR) agonist...

  • Gene Expression-Based Chemical Genomics Identifies Potential Therapeutic Drugs in Hepatocellular Carcinoma. Ming-Huang Chen; Yang, Wu-Lung R.; Kuan-Ting Lin; Chia-Hung Liu; Yu-Wen Liu; Kai-Wen Huang; Chang, Peter Mu-Hsin; Jin-Mei Lai; Chun-Nan Hsu; Kun-Mao Chao; Cheng-Yan Kao; Huang, Chi-Ying F. // PLoS ONE;2011, Vol. 6 Issue 11, p1 

    Hepatocellular carcinoma (HCC) is an aggressive tumor with a poor prognosis. Currently, only sorafenib is approved by the FDA for advanced HCC treatment; therefore, there is an urgent need to discover candidate therapeutic drugs for HCC. We hypothesized that if a drug signature could reverse, at...

  • Editorial. Elgar, Greg // Briefings in Functional Genomics & Proteomics;Feb2004, Vol. 2 Issue 4, p277 

    Provides information on articles on functional genomics and proteomics. Approaches to systems biology; Gap between researchers over networking in systems biology; Views of biologists on in vitro system; Relationship between gene expression and chromatin structure.

  • Integrating Transcriptomics and Proteomics. Chan, Eric // Genomics & Proteomics;Apr2006, Vol. 6 Issue 3, p20 

    The article discusses the integration of transcriptomics and proteomics in gene expression analyses. Protein and transcript levels deal with the provision of a functional activity in the affected biological function due to gene-to-gene interaction networks. With the study on expression analyses...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics